American Oriental Bioengineering, Inc. Stock Other OTC
Equities
AOBI
US0287315032
Pharmaceuticals
Sales 2011 | 213M 292M | Sales 2012 | 145M 200M | Capitalization | 13.35M 18.35M |
---|---|---|---|---|---|
Net income 2011 | -67M -92.13M | Net income 2012 | -59M -81.13M | EV / Sales 2011 | 0.5 x |
Net Debt 2011 | 63.31M 87.06M | Net Debt 2012 | 49.49M 68.05M | EV / Sales 2012 | 0.43 x |
P/E ratio 2011 |
-0.62
x | P/E ratio 2012 |
-0.22
x | Employees | - |
Yield 2011 * |
-
| Yield 2012 |
-
| Free-Float | 5.48% |
Managers | Title | Age | Since |
---|---|---|---|
Yan Chun Li
FOU | Founder | 55 | - |
Shujun Liu
CEO | Chief Executive Officer | 71 | 70-11-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shujun Liu
CEO | Chief Executive Officer | 71 | 70-11-29 |
Yan Chun Li
FOU | Founder | 55 | - |
1st Jan change | Capi. | |
---|---|---|
+32.50% | 664B | |
+29.29% | 567B | |
-6.93% | 354B | |
+19.86% | 330B | |
+4.70% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.93% | 148B |